THE IRON OF THE FUTURE. TODAY.
Novel and certified iron supplement
With IHAT™ technology, tolfer® defines new safety and tolerability standards in managing iron deficiency. IHAT™ is the first and only nanoparticulate novel food that is approved by the European Food Safety Authority (EFSA).
Innovative and patented technology
More than 12 years of dedicated research have crafted tolfer®’s innovative technology mimicking physiological and most advanced iron delivery for a revolutionary approach to iron health, setting it apart from conventional sources of iron.
Unmatched safety and tolerability
Our innovative technology was developed with a priority focus on safety to guarantee long-term wellbeing for people with iron deficiency. Thanks to its unique tolerability profile, it favours treatment adherence and effective restoration of optimal iron levels.
Maria Cristina Comelli,
R&D Director
“IHAT™ was designed and developed as an analogue of ferritin, respecting the physiology and correct metabolism of iron in a deficient state. For this reason, IHAT™ doesn’t present the significant and persistent tolerability obstacles linked to the typical iron supplements, such as poor adherence to the treatment and reduced recovery from anemia.
EFSA’s recognition of the safety and bioavailability of IHAT™ in iron deficiency – guaranteed by an excellent toxicological profile, the absence of iron overload in sensitive organs and tissues, unique non-pro-inflammatory characteristics, and respect for the human microbiome – offers patients and prescribers the most advanced safety profile in the field of iron deficiency management.”